The global coagulation disorders market is experiencing robust growth, primarily fueled by the rising prevalence of bleeding disorders such as hemophilia and von Willebrand disease. Awareness of these conditions is expanding, complemented by significant improvements in diagnostic technologies that enhance detection capabilities. Recent advancements in treatment modalities, including innovative...